OUR PRODUCTS

MOBILE APPS

GENERAL INFO

BRNS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Barinthus Biotherapeutics (BRNS) Earnings Date & Reports

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BRNS is expected to report earnings to fall 34.62% to -34 cents per share on November 06

Barinthus Biotherapeutics BRNS Stock Earnings Reports

Q3'25

Est.

$-0.34

Q2'25

Missed

by $0.16

Q1'25

Missed

by $0.13

Q4'24

Missed

by $0.05

Q3'24

Beat

by $0.23

The last earnings report on August 07 showed earnings per share of -51 cents, missing the estimate of -36 cents. With 66.02K shares outstanding, the current market capitalization sits at 54.05M.

View a ticker or compare two or three

Compare

BRNS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BRNS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BRNS showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Unit 6-10, Rutherford Avenue

Phone

+44 1865818808

Employees

Web

https://www.barinthusbio.com